Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers

Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers

Ovarian cancers encompass a group of neoplasms originating from germinal tissues and exhibiting distinct clinical, pathological, and molecular features. Among these, epithelial ovarian cancers (EOCs) are the most prevalent, comprising five distinct tumor histotypes. Notably, high-grade serous ovaria...

Full description

Bibliographic Details
Main Authors:	Eros Azzalini, Giorgio Stanta, Vincenzo Canzonieri, Serena Bonin
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	International Journal of Molecular Sciences
Subjects:	HGSOC intratumor heterogeneity SET classic clonal evolution TME
Online Access:	https://www.mdpi.com/1422-0067/24/20/15077

Similar Items

AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
by: Eros Azzalini, et al.
Published: (2022-01-01)

Overview on Clinical Relevance of Intra-Tumor Heterogeneity
by: Giorgio Stanta, et al.
Published: (2018-04-01)

A Comprehensive Analysis of Prognostic Indicators in Serous Ovarian Cancer Based on Leukocyte Migration and Immune Microenvironment
by: Junping Pan, et al.
Published: (2023-06-01)

Low Expression of Circular RNA hsa_circ_0078607 Predicts Poor Prognosis in High-Grade Serous Ovarian Cancer
by: Zhang N, et al.
Published: (2021-03-01)

Combining Mass Cytometry Data by CyTOFmerge Reveals Additional Cell Phenotypes in the Heterogeneous Ovarian Cancer Tumor Microenvironment: A Pilot Study
by: Liv Cecilie Vestrheim Thomsen, et al.
Published: (2023-10-01)

The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis
by: Cai M. Roberts, et al.
Published: (2019-07-01)

Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer
by: Jie Zhang, et al.
Published: (2022-07-01)

Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis
by: Wenhui Zhang, et al.
Published: (2022-02-01)

Clonal Evolution of <i>TP53</i> c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC)
by: Marica Garziera, et al.
Published: (2019-10-01)

Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins
by: Cecilie Fredvik Torkildsen, et al.
Published: (2023-03-01)

HDAC6 Degradation Inhibits the Growth of High-Grade Serous Ovarian Cancer Cells
by: Ahlam Ali, et al.
Published: (2020-12-01)

Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non‐small cell lung cancers
by: Jia−Tao Zhang, et al.
Published: (2022-05-01)

Intratumor heterogeneity: A new perspective on colorectal cancer research
by: Zicheng Zheng, et al.
Published: (2020-10-01)

Epigenetic heterogeneity in cancer
by: Mingzhou Guo, et al.
Published: (2019-10-01)

Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues
by: Meifu Gan, et al.
Published: (2023-01-01)

Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging
by: Hagen Kulbe, et al.
Published: (2020-07-01)

The clonal expression genes associated with poor prognosis of liver cancer
by: Wanfeng Zhang, et al.
Published: (2022-08-01)

Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples
by: Anna M. J. van Nistelrooij, et al.
Published: (2017-04-01)

Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer
by: Yann Kieffer, et al.
Published: (2020-03-01)

Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancer
by: Monika Raab, et al.
Published: (2024-01-01)

Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
by: Lu Zhang, et al.
Published: (2021-11-01)

Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer
by: Inga Hoffmann, et al.
Published: (2023-10-01)

High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma
by: Paul Jank, et al.
Published: (2023-07-01)

What’s beyond BRCA Mutational Status in High Grade Serous Ovarian Cancer? The Impact of Hormone Receptor Expression in a Large BRCA-Profiled Ovarian Cancer Patient Series: A Retrospective Cohort Study
by: Emanuele Perrone, et al.
Published: (2022-09-01)

PTPN13 Participates in the Regulation of Epithelial–Mesenchymal Transition and Platinum Sensitivity in High-Grade Serous Ovarian Carcinoma Cells
by: Leticia Aptecar, et al.
Published: (2023-10-01)

MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma
by: Lili Zhong, et al.
Published: (2022-01-01)

Establishment of a prognostic model for ovarian cancer based on mitochondrial metabolism-related genes
by: Chao Meng, et al.
Published: (2023-05-01)

Higher Mutation Burden in High Proliferation Compartments of Heterogeneous Melanoma Tumors
by: Tomasz M. Grzywa, et al.
Published: (2021-04-01)

CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
by: Katrin Kleinmanns, et al.
Published: (2020-06-01)

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types
by: Masaki Kobayashi, et al.
Published: (2018-09-01)

Characteristics of Extracellular Vesicles from a High-Grade Serous Ovarian Cancer Cell Line Derived from a Platinum-Resistant Patient as a Potential Tool for Aiding the Prediction of Responses to Chemotherapy
by: Katarina Černe, et al.
Published: (2023-06-01)

Genetic Evidence for Early Peritoneal Spreading in Pelvic High-Grade Serous Cancer
by: Jeremy Chien, et al.
Published: (2018-03-01)

Synergistic Sensitization of High-Grade Serous Ovarian Cancer Cells Lacking Caspase-8 Expression to Chemotherapeutics Using Combinations of Small-Molecule BRD4 and CDK9 Inhibitors
by: Khayal Gasimli, et al.
Published: (2023-12-01)

Evaluation of Collagen Alterations in Early Precursor Lesions of High Grade Serous Ovarian Cancer by Second Harmonic Generation Microscopy and Mass Spectrometry
by: Kristal L. Gant, et al.
Published: (2021-06-01)

VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinoma
by: Aida Jlassi, et al.
Published: (2024-04-01)

Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response
by: Mairinger F, et al.
Published: (2019-11-01)

Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications
by: Emma Zattarin, et al.
Published: (2020-12-01)

Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique
by: Valerie Heong, et al.
Published: (2020-06-01)

Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment
by: Marcus Vetter, et al.
Published: (2022-11-01)

High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report
by: Paola Giancontieri, et al.
Published: (2024-02-01)